Sotera Health Company (SHC)

Market Cap	3.08B
Revenue (ttm)	1.05B
Net Income (ttm)	51.38M
Shares Out	282.83M
EPS (ttm)	0.18
PE Ratio	60.72
Forward PE	15.19
Dividend	n/a
Ex-Dividend Date	n/a

Volume	681,826
Open	10.74
Previous Close	10.75
Day's Range	10.71 - 10.99
52-Week Range	10.71 - 19.40
Beta	2.11
Analysts	Buy
Price Target	17.70 (+62.39%)
Earnings Date	May 2, 2024

About SHC

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems. The company also provides microbiological and analytical chemistry testing, as well as technical assistance, re...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: Nov 20, 2020
• Employees: 3,000
• Stock Exchange: NASDAQ
• Ticker Symbol: SHC

Analyst Forecast

According to 6 analysts, the average rating for SHC stock is "Buy." The 12-month stock price forecast is $17.7, which is an increase of 62.39% from the latest price.

Price Target

$17.7

(62.39% upside)

Analyst Consensus: Buy